Instrument Inactif

Communiqués Boston Therapeutics, Inc. Other OTC

Actions

BTHE

US1011501004

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Nanomix Announces Equity Investment from Senior Executive of Woodley Equipment Company, Ltd. at a Premium to Market	13/04/23	GL
NANOMIX CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	07/04/23	AQ
NANOMIX CORP : Regulation FD Disclosure (form 8-K)	10/03/23	AQ
NANOMIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	25/01/23	AQ
Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer	25/01/23	GL
Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer	25/01/23	GL
Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy	29/11/22	GL
Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy	29/11/22	GL
NANOMIX CORP : Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	10/11/22	AQ
Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.	09/11/22	GL
Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.	09/11/22	AQ
Nanomix Enters into Multi-Country Distribution Agreement for the eLab System with Mast Group Limited	04/11/22	GL
Nanomix Enters into Multi-Country Distribution Agreement for the eLab System with Mast Group Limited	04/11/22	AQ
Nanomix Enters into Distribution Agreement for the eLab System with Diaclinic SpA in Chile	20/10/22	GL
Nanomix Enters into Distribution Agreement for the eLab System with Diaclinic SpA in Chile	20/10/22	AQ
Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with IPS Genomix s.a.l. in the Middle East	12/09/22	GL
Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with IPS Genomix s.a.l. in the Middle East	12/09/22	AQ
NANOMIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	09/09/22	AQ
Nanomix Announces Agreement with Mobility Health to Co-Develop a Lab Development Test for Evaluating Levels of COVID-19 Circulating Antibodies	02/09/22	GL
Nanomix Announces Agreement with Mobility Health to Co-Develop a Lab Development Test for Evaluating Levels of COVID-19 Circulating Antibodies	02/09/22	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Boston Therapeutics, Inc. Other OTC

Actions

BTHE

US1011501004

Communiqués

Filtres